Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures

被引：2
|
作者：
Brown, Beatrice L.
Kesselheim, Aaron S.
Sarpatwari, Ameet [1 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoeconom, Boston, MA 02115 USA
来源：
PLOS MEDICINE | 2023年 / 20卷 / 03期
关键词：
MEDICATIONS; PREGNANCY; KNOWLEDGE;
D O I：
10.1371/journal.pmed.1004190
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In an analysis of risk evaluation and mitigation strategies for teratogenic drugs, Ameet Sarpatwari, Beatrice Brown and Aaron Kesselheim explore the variation in primary and secondary prevention measures.
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies
    Sarayani, Amir
    Albogami, Yasser
    Thai, Thuy Nhu
    Smolinski, Nicole E.
    Patel, Preya
    Wang, Yanning
    Nduaguba, Sabina
    Rasmussen, Sonja A.
    Winterstein, Almut G.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 227 (02)
  • [2] Prenatal exposure to teratogenic medications in the era of risk evaluation and mitigation strategies (REMS)
    Sarayani, Amir
    Albogami, Yasser
    Wang, Xi
    Thai, Thuy
    Smolinski, Nicole E.
    Patel, Preya
    Nduaguba, Sabina
    Rasmussen, Sonja A.
    Winterstein, Almut G.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 307 - 307
  • [3] A Retrospective Analysis of Adherence to Risk Evaluation and Mitigation Strategies Requirements for Pulmonary Arterial Hypertension Drugs
    Prokes, Mackenzie
    Root, Adam
    [J]. HOSPITAL PHARMACY, 2019, 54 (05) : 309 - 313
  • [4] Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition
    Sarpatwari, Ameet
    Kohli, Sajeev
    Tu, S. Sean
    Kesselheim, Aaron S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (11): : 976 - 978
  • [5] Risk Evaluation and Mitigation Strategies
    Schneider, Philip J.
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2012, 8 (09): : 747 - 748
  • [6] Strategies for primary and secondary stroke prevention
    Brass, Lawrence M.
    [J]. CLINICAL CARDIOLOGY, 2006, 29 (10) : 21 - 27
  • [7] A comprehensive review on the teratogenic risks for twelve drugs with risk evaluation and mitigation strategy (REMS) to prevent prenatal exposure
    Aydogan, Tansu Miriam Isilay
    Smolinski, Nicole
    Thai, Thuy
    Jugl, Sebastian
    Sarayani, Amir
    Ewig, Celeste
    Winterstein, Almut
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 151 - 151
  • [8] Assessment of Risk Evaluation and Mitigation Strategies in Oncology: Summary of the Oncology Risk Evaluation and Mitigation Strategies Workshop
    Frame, James N.
    Jacobson, Joseph O.
    Vogel, Wendy H.
    Griffith, Niesha
    Wariabharaj, Darshan
    Garg, Rekha
    Zon, Robin
    Stephens, Cyntha L.
    Bialecki, Alison M.
    Bruinooge, Suanna S.
    Allen, Steven L.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (02) : E24 - E39
  • [9] Evaluation of Current Risk Evaluation and Mitigation Strategies
    Gilsenan, Alicia
    Andrews, Elizabeth B.
    Calingaert, Brian
    Crozier, Debra
    Vanderpuije, Abenah
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S177 - S178
  • [10] An introduction to risk evaluation and mitigation strategies
    Dohm, Julie
    Ji, Mingham
    [J]. CONTRACEPTION, 2021, 104 (01) : 4 - 7
12345